STOCK TITAN

[Form 4] Modular Medical, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Barclays Bank PLC is marketing a new two-year structured note—Capped Buffer GEARS—tied to the price performance of the S&P 500® Index. Each $10 Security offers 2.0× leveraged participation in any positive index return, but gains are capped at 21.65-23.65% (exact rate set on the July 15, 2025 Trade Date). Investors receive:

  • Full principal repayment at maturity if the Index is flat or down less than 10% (Buffer).
  • Loss exposure of 1% for every 1% decline beyond the 10% Buffer, up to a maximum 90% loss of principal.

Key indicative terms include a Downside Threshold at 90% of the Initial Index Level, Upside Gearing of 2.0, no periodic coupons, and maturity on July 20, 2027. The notes price at par ($10), yet Barclays’ internal models estimate fair value between $9.459-$9.959, reflecting embedded selling concessions, hedging costs and issuer profit. UBS Financial Services acts as placement agent for fee-based advisory accounts; no sales commission is paid.

Risk considerations dominate the disclosure: the notes are unsecured, unsubordinated obligations of Barclays and subject to U.K. bail-in powers, market risk of the S&P 500, limited liquidity (no exchange listing and discretionary secondary market making only), tax uncertainty (potential prepaid forward contract treatment), and valuation risk (secondary prices likely below issue price).

Illustrative payoff scenarios show that a 30% Index gain yields the maximum $12.165 payment, while a 60% decline results in only $5.00—demonstrating the capped upside and buffered but significant downside.

Barclays Bank PLC propone un nuovo titolo strutturato biennale—Capped Buffer GEARS—collegato alla performance del prezzo dell'indice S&P 500®. Ogni titolo da $10 offre una partecipazione con leva 2.0× su qualsiasi rendimento positivo dell'indice, ma i guadagni sono limitati al 21,65-23,65% (tasso esatto fissato il 15 luglio 2025, data di negoziazione). Gli investitori ricevono:

  • Rimborso integrale del capitale a scadenza se l'indice rimane invariato o scende di meno del 10% (Buffer).
  • Esposizione alla perdita dell'1% per ogni 1% di calo oltre il buffer del 10%, fino a una perdita massima del 90% del capitale.

I principali termini indicativi includono una soglia di ribasso al 90% del livello iniziale dell'indice, leva al rialzo di 2.0, nessuna cedola periodica e scadenza il 20 luglio 2027. I titoli sono quotati a pari ($10), ma i modelli interni di Barclays stimano un valore equo compreso tra $9,459 e $9,959, riflettendo commissioni di vendita incorporate, costi di copertura e profitto dell'emittente. UBS Financial Services agisce come agente di collocamento per conti consulenziali a commissioni; non viene pagata alcuna commissione di vendita.

Considerazioni sui rischi sono al centro dell'informativa: i titoli sono obbligazioni non garantite e non subordinate di Barclays, soggette ai poteri di bail-in del Regno Unito, rischio di mercato legato all'S&P 500, liquidità limitata (nessuna quotazione in borsa e mercato secondario gestito discrezionalmente), incertezza fiscale (possibile trattamento come contratto a termine prepagato) e rischio di valutazione (prezzi secondari probabilmente inferiori al prezzo d'emissione).

Scenari illustrativi di rendimento mostrano che un rialzo del 30% dell'indice produce il pagamento massimo di $12,165, mentre un calo del 60% comporta solo $5,00—dimostrando il limite al rialzo e il buffer ma con un significativo downside.

Barclays Bank PLC está lanzando una nueva nota estructurada a dos años—Capped Buffer GEARS—vinculada al desempeño del precio del índice S&P 500®. Cada título de $10 ofrece una participación apalancada de 2.0× en cualquier rendimiento positivo del índice, pero las ganancias están limitadas entre 21.65% y 23.65% (tasa exacta fijada el 15 de julio de 2025, fecha de negociación). Los inversores reciben:

  • Reembolso total del capital al vencimiento si el índice está estable o baja menos del 10% (Buffer).
  • Exposición a pérdidas del 1% por cada 1% de caída que supere el buffer del 10%, hasta una pérdida máxima del 90% del capital.

Los términos indicativos clave incluyen un umbral a la baja del 90% del nivel inicial del índice, apalancamiento al alza de 2.0, sin cupones periódicos y vencimiento el 20 de julio de 2027. Las notas se cotizan a la par ($10), pero los modelos internos de Barclays estiman un valor justo entre $9.459 y $9.959, reflejando concesiones de venta incorporadas, costos de cobertura y beneficio del emisor. UBS Financial Services actúa como agente colocador para cuentas asesoradas con honorarios; no se paga comisión de venta.

Consideraciones de riesgo dominan la divulgación: las notas son obligaciones no garantizadas y no subordinadas de Barclays, sujetas a los poderes de rescate del Reino Unido, riesgo de mercado del S&P 500, liquidez limitada (sin cotización en bolsa y mercado secundario discrecional), incertidumbre fiscal (posible tratamiento como contrato forward prepagado) y riesgo de valoración (precios secundarios probablemente por debajo del precio de emisión).

Escenarios ilustrativos de pago muestran que una ganancia del 30% en el índice genera el pago máximo de $12.165, mientras que una caída del 60% resulta en solo $5.00—demostrando el límite al alza y el buffer pero con una caída significativa.

Barclays Bank PLC는 S&P 500® 지수의 가격 성과에 연동된 새로운 2년 만기 구조화 상품—Capped Buffer GEARS—를 출시합니다. 각 $10 증권은 긍정적인 지수 수익에 대해 2.0배 레버리지 참여를 제공하지만, 수익은 21.65-23.65%상한이 설정되어 있습니다 (정확한 비율은 2025년 7월 15일 거래일에 확정). 투자자는 다음을 받습니다:

  • 지수가 변동 없거나 10% 미만 하락 시 만기 시 원금 전액 상환 (Buffer).
  • 10% 버퍼를 초과하는 하락에 대해 1% 하락마다 1% 손실 노출, 최대 원금 90% 손실까지.

주요 조건으로는 초기 지수 수준의 90%에 하락 임계값 설정, 2.0배 상승 레버리지, 정기 쿠폰 없음, 2027년 7월 20일 만기 등이 포함됩니다. 증권은 액면가($10)로 가격이 책정되었으나, Barclays 내부 모델은 판매 수수료, 헤징 비용 및 발행자 이익을 반영하여 공정 가치를 $9.459-$9.959로 추정합니다. UBS Financial Services는 수수료 기반 자문 계좌의 배치 대리인 역할을 하며, 판매 수수료는 지급되지 않습니다.

위험 고려사항이 공개의 핵심입니다: 이 증권은 Barclays의 무담보, 비후순위 채무이며 영국의 구제 금융 권한 대상이고, S&P 500의 시장 위험, 제한된 유동성(거래소 상장 없음 및 임의의 2차 시장 조성), 세금 불확실성(선불 선도계약 처리 가능성), 평가 위험(2차 시장 가격이 발행가 이하일 가능성)이 있습니다.

예시 수익 시나리오에 따르면 지수가 30% 상승하면 최대 $12.165를 지급하며, 60% 하락 시 $5.00만 지급되어 상한 수익과 버퍼가 있으나 상당한 하락 위험을 보여줍니다.

Barclays Bank PLC commercialise une nouvelle note structurée de deux ans—Capped Buffer GEARS—liée à la performance du prix de l'indice S&P 500®. Chaque titre de 10 $ offre une participation à effet de levier de 2,0× sur tout rendement positif de l'indice, mais les gains sont plafonnés entre 21,65 % et 23,65 % (taux exact fixé à la date de transaction du 15 juillet 2025). Les investisseurs bénéficient de :

  • Remboursement intégral du capital à l'échéance si l'indice est stable ou baisse de moins de 10 % (Buffer).
  • Exposition à la perte de 1 % pour chaque baisse de 1 % au-delà du buffer de 10 %, jusqu'à une perte maximale de 90 % du capital.

Les principales conditions indicatives incluent un seuil de baisse à 90 % du niveau initial de l'indice, un effet de levier à la hausse de 2,0, pas de coupons périodiques, et une échéance au 20 juillet 2027. Les notes sont émises à leur valeur nominale (10 $), mais les modèles internes de Barclays estiment une juste valeur comprise entre 9,459 $ et 9,959 $, reflétant les concessions de vente intégrées, les coûts de couverture et la marge de l'émetteur. UBS Financial Services agit en tant qu'agent de placement pour les comptes de conseil à honoraires ; aucune commission de vente n'est versée.

Les considérations de risque dominent la divulgation : les notes sont des obligations non garanties et non subordonnées de Barclays, soumises aux pouvoirs de renflouement interne du Royaume-Uni, au risque de marché lié au S&P 500, à une liquidité limitée (pas de cotation en bourse et marché secondaire discrétionnaire), à une incertitude fiscale (traitement possible en tant que contrat à terme prépayé) et à un risque d'évaluation (prix secondaires probablement inférieurs au prix d'émission).

Des scénarios illustratifs montrent qu'une hausse de 30 % de l'indice donne lieu au paiement maximal de 12,165 $, tandis qu'une baisse de 60 % entraîne un paiement de seulement 5,00 $—démontrant la limite à la hausse et le buffer mais avec un risque de baisse significatif.

Barclays Bank PLC bietet eine neue zweijährige strukturierte Note—Capped Buffer GEARS—an, die an die Kursentwicklung des S&P 500® Index gekoppelt ist. Jede $10-Anleihe bietet eine 2,0-fache Hebelwirkung auf positive Indexrenditen, jedoch sind die Gewinne auf 21,65-23,65% begrenzt (exakter Satz wird am 15. Juli 2025, dem Handelstag, festgelegt). Anleger erhalten:

  • Volle Rückzahlung des Kapitals bei Fälligkeit, wenn der Index unverändert bleibt oder weniger als 10% fällt (Buffer).
  • Verlustaussetzung von 1% für jeden 1%igen Rückgang über den 10% Buffer hinaus, bis zu einem maximalen Verlust von 90% des Kapitals.

Wesentliche indikative Bedingungen umfassen eine Abwärtsschwelle bei 90% des Anfangsindexniveaus, eine Aufwärtshebelung von 2,0, keine periodischen Kupons und Fälligkeit am 20. Juli 2027. Die Notes werden zum Nennwert ($10) begeben, doch schätzen Barclays interne Modelle den fairen Wert zwischen $9,459 und $9,959, was eingebettete Verkaufsprovisionen, Absicherungskosten und Emittentenmarge widerspiegelt. UBS Financial Services fungiert als Platzierungsagent für gebührenbasierte Beratungskonten; es werden keine Verkaufsprovisionen gezahlt.

Risikohinweise dominieren die Offenlegung: Die Notes sind unbesicherte, nicht nachrangige Verbindlichkeiten von Barclays und unterliegen den Bail-in-Maßnahmen des Vereinigten Königreichs, dem Marktrisiko des S&P 500, begrenzter Liquidität (keine Börsennotierung und diskretionäres Sekundärmarkt-Making), steuerlicher Unsicherheit (mögliche Behandlung als vorausbezahlter Terminkontrakt) und Bewertungsrisiko (Sekundärmarktpreise wahrscheinlich unter dem Ausgabepreis).

Beispielszenarien zeigen, dass ein Indexanstieg von 30% die maximale Zahlung von $12,165 ergibt, während ein Rückgang von 60% nur $5,00 einbringt—was das begrenzte Aufwärtspotenzial und den gepufferten, aber erheblichen Abwärtsrisiko verdeutlicht.

Positive
  • 2.0× Upside Gearing provides leveraged participation in moderate index rallies, enhancing potential returns versus a direct S&P 500 investment within the capped range.
  • 10% downside buffer offers partial protection against small to mid-single-digit index declines, fully preserving principal if losses remain within the buffer.
  • Short 2-year maturity limits duration and interest-rate exposure compared with longer-dated structured products.
Negative
  • Maximum Gain capped at 21.65-23.65%, limiting upside even if the S&P 500 appreciates strongly over two years.
  • Principal loss up to 90% if the index falls more than 10%, exposing investors to severe equity-like downside.
  • Issuer credit & bail-in risk: payments depend on Barclays’ solvency; U.K. resolution authority can write down the notes.
  • Estimated fair value below issue price ($9.459-$9.959), meaning investors incur an immediate mark-to-model loss at settlement.
  • No periodic interest and limited liquidity; notes are not exchange-listed and market making is discretionary.
  • Tax treatment uncertain; IRS could challenge prepaid forward characterization, altering after-tax returns.

Insights

TL;DR Short-dated equity-linked note offers 2× upside with 10% buffer but capped at ~22%; downside, liquidity and credit risks are material.

The product targets advisory clients seeking leveraged, buffered equity exposure in a tax-efficient wrapper. Relative to traditional 1.0× buffered notes, the 2.0 Upside Gearing is attractive, yet the cap limits effective annualized return to roughly 10-11% if held to maturity. The 10% buffer is modest; historical two-year drawdowns of the S&P 500 exceed this threshold roughly 25-30% of the time, meaning probability-weighted loss potential is non-trivial. Note value is further eroded by a modeled OAS of ~45-55 bps versus par, implying an immediate 0.4-0.5 point premium paid by investors. Lack of coupon income and no secondary market listing reduce flexibility. Overall, payoff asymmetry favors the issuer unless investors have a strong, range-bound bullish view.

TL;DR Payments hinge on Barclays’ senior unsecured credit; bail-in language makes these notes effectively loss-absorbing instruments.

Although Barclays remains investment-grade (A/A-/A1), its senior debt trades with CDS spreads near 85 bps. Investors accept equivalent credit exposure in addition to market risk. The explicit consent to U.K. bail-in power elevates statutory loss-absorption risk versus comparable U.S. bank notes. Should Barclays enter resolution, principal can be written down or converted to equity with no event of default. Given the two-year tenor, default probability is low but non-zero; the incremental spread versus risk-free Treasuries (~120 bps all-in) provides limited compensation when adjusted for the embedded option value paid by investors. I classify the credit component as neutral to slightly negative for risk-averse buyers.

Barclays Bank PLC propone un nuovo titolo strutturato biennale—Capped Buffer GEARS—collegato alla performance del prezzo dell'indice S&P 500®. Ogni titolo da $10 offre una partecipazione con leva 2.0× su qualsiasi rendimento positivo dell'indice, ma i guadagni sono limitati al 21,65-23,65% (tasso esatto fissato il 15 luglio 2025, data di negoziazione). Gli investitori ricevono:

  • Rimborso integrale del capitale a scadenza se l'indice rimane invariato o scende di meno del 10% (Buffer).
  • Esposizione alla perdita dell'1% per ogni 1% di calo oltre il buffer del 10%, fino a una perdita massima del 90% del capitale.

I principali termini indicativi includono una soglia di ribasso al 90% del livello iniziale dell'indice, leva al rialzo di 2.0, nessuna cedola periodica e scadenza il 20 luglio 2027. I titoli sono quotati a pari ($10), ma i modelli interni di Barclays stimano un valore equo compreso tra $9,459 e $9,959, riflettendo commissioni di vendita incorporate, costi di copertura e profitto dell'emittente. UBS Financial Services agisce come agente di collocamento per conti consulenziali a commissioni; non viene pagata alcuna commissione di vendita.

Considerazioni sui rischi sono al centro dell'informativa: i titoli sono obbligazioni non garantite e non subordinate di Barclays, soggette ai poteri di bail-in del Regno Unito, rischio di mercato legato all'S&P 500, liquidità limitata (nessuna quotazione in borsa e mercato secondario gestito discrezionalmente), incertezza fiscale (possibile trattamento come contratto a termine prepagato) e rischio di valutazione (prezzi secondari probabilmente inferiori al prezzo d'emissione).

Scenari illustrativi di rendimento mostrano che un rialzo del 30% dell'indice produce il pagamento massimo di $12,165, mentre un calo del 60% comporta solo $5,00—dimostrando il limite al rialzo e il buffer ma con un significativo downside.

Barclays Bank PLC está lanzando una nueva nota estructurada a dos años—Capped Buffer GEARS—vinculada al desempeño del precio del índice S&P 500®. Cada título de $10 ofrece una participación apalancada de 2.0× en cualquier rendimiento positivo del índice, pero las ganancias están limitadas entre 21.65% y 23.65% (tasa exacta fijada el 15 de julio de 2025, fecha de negociación). Los inversores reciben:

  • Reembolso total del capital al vencimiento si el índice está estable o baja menos del 10% (Buffer).
  • Exposición a pérdidas del 1% por cada 1% de caída que supere el buffer del 10%, hasta una pérdida máxima del 90% del capital.

Los términos indicativos clave incluyen un umbral a la baja del 90% del nivel inicial del índice, apalancamiento al alza de 2.0, sin cupones periódicos y vencimiento el 20 de julio de 2027. Las notas se cotizan a la par ($10), pero los modelos internos de Barclays estiman un valor justo entre $9.459 y $9.959, reflejando concesiones de venta incorporadas, costos de cobertura y beneficio del emisor. UBS Financial Services actúa como agente colocador para cuentas asesoradas con honorarios; no se paga comisión de venta.

Consideraciones de riesgo dominan la divulgación: las notas son obligaciones no garantizadas y no subordinadas de Barclays, sujetas a los poderes de rescate del Reino Unido, riesgo de mercado del S&P 500, liquidez limitada (sin cotización en bolsa y mercado secundario discrecional), incertidumbre fiscal (posible tratamiento como contrato forward prepagado) y riesgo de valoración (precios secundarios probablemente por debajo del precio de emisión).

Escenarios ilustrativos de pago muestran que una ganancia del 30% en el índice genera el pago máximo de $12.165, mientras que una caída del 60% resulta en solo $5.00—demostrando el límite al alza y el buffer pero con una caída significativa.

Barclays Bank PLC는 S&P 500® 지수의 가격 성과에 연동된 새로운 2년 만기 구조화 상품—Capped Buffer GEARS—를 출시합니다. 각 $10 증권은 긍정적인 지수 수익에 대해 2.0배 레버리지 참여를 제공하지만, 수익은 21.65-23.65%상한이 설정되어 있습니다 (정확한 비율은 2025년 7월 15일 거래일에 확정). 투자자는 다음을 받습니다:

  • 지수가 변동 없거나 10% 미만 하락 시 만기 시 원금 전액 상환 (Buffer).
  • 10% 버퍼를 초과하는 하락에 대해 1% 하락마다 1% 손실 노출, 최대 원금 90% 손실까지.

주요 조건으로는 초기 지수 수준의 90%에 하락 임계값 설정, 2.0배 상승 레버리지, 정기 쿠폰 없음, 2027년 7월 20일 만기 등이 포함됩니다. 증권은 액면가($10)로 가격이 책정되었으나, Barclays 내부 모델은 판매 수수료, 헤징 비용 및 발행자 이익을 반영하여 공정 가치를 $9.459-$9.959로 추정합니다. UBS Financial Services는 수수료 기반 자문 계좌의 배치 대리인 역할을 하며, 판매 수수료는 지급되지 않습니다.

위험 고려사항이 공개의 핵심입니다: 이 증권은 Barclays의 무담보, 비후순위 채무이며 영국의 구제 금융 권한 대상이고, S&P 500의 시장 위험, 제한된 유동성(거래소 상장 없음 및 임의의 2차 시장 조성), 세금 불확실성(선불 선도계약 처리 가능성), 평가 위험(2차 시장 가격이 발행가 이하일 가능성)이 있습니다.

예시 수익 시나리오에 따르면 지수가 30% 상승하면 최대 $12.165를 지급하며, 60% 하락 시 $5.00만 지급되어 상한 수익과 버퍼가 있으나 상당한 하락 위험을 보여줍니다.

Barclays Bank PLC commercialise une nouvelle note structurée de deux ans—Capped Buffer GEARS—liée à la performance du prix de l'indice S&P 500®. Chaque titre de 10 $ offre une participation à effet de levier de 2,0× sur tout rendement positif de l'indice, mais les gains sont plafonnés entre 21,65 % et 23,65 % (taux exact fixé à la date de transaction du 15 juillet 2025). Les investisseurs bénéficient de :

  • Remboursement intégral du capital à l'échéance si l'indice est stable ou baisse de moins de 10 % (Buffer).
  • Exposition à la perte de 1 % pour chaque baisse de 1 % au-delà du buffer de 10 %, jusqu'à une perte maximale de 90 % du capital.

Les principales conditions indicatives incluent un seuil de baisse à 90 % du niveau initial de l'indice, un effet de levier à la hausse de 2,0, pas de coupons périodiques, et une échéance au 20 juillet 2027. Les notes sont émises à leur valeur nominale (10 $), mais les modèles internes de Barclays estiment une juste valeur comprise entre 9,459 $ et 9,959 $, reflétant les concessions de vente intégrées, les coûts de couverture et la marge de l'émetteur. UBS Financial Services agit en tant qu'agent de placement pour les comptes de conseil à honoraires ; aucune commission de vente n'est versée.

Les considérations de risque dominent la divulgation : les notes sont des obligations non garanties et non subordonnées de Barclays, soumises aux pouvoirs de renflouement interne du Royaume-Uni, au risque de marché lié au S&P 500, à une liquidité limitée (pas de cotation en bourse et marché secondaire discrétionnaire), à une incertitude fiscale (traitement possible en tant que contrat à terme prépayé) et à un risque d'évaluation (prix secondaires probablement inférieurs au prix d'émission).

Des scénarios illustratifs montrent qu'une hausse de 30 % de l'indice donne lieu au paiement maximal de 12,165 $, tandis qu'une baisse de 60 % entraîne un paiement de seulement 5,00 $—démontrant la limite à la hausse et le buffer mais avec un risque de baisse significatif.

Barclays Bank PLC bietet eine neue zweijährige strukturierte Note—Capped Buffer GEARS—an, die an die Kursentwicklung des S&P 500® Index gekoppelt ist. Jede $10-Anleihe bietet eine 2,0-fache Hebelwirkung auf positive Indexrenditen, jedoch sind die Gewinne auf 21,65-23,65% begrenzt (exakter Satz wird am 15. Juli 2025, dem Handelstag, festgelegt). Anleger erhalten:

  • Volle Rückzahlung des Kapitals bei Fälligkeit, wenn der Index unverändert bleibt oder weniger als 10% fällt (Buffer).
  • Verlustaussetzung von 1% für jeden 1%igen Rückgang über den 10% Buffer hinaus, bis zu einem maximalen Verlust von 90% des Kapitals.

Wesentliche indikative Bedingungen umfassen eine Abwärtsschwelle bei 90% des Anfangsindexniveaus, eine Aufwärtshebelung von 2,0, keine periodischen Kupons und Fälligkeit am 20. Juli 2027. Die Notes werden zum Nennwert ($10) begeben, doch schätzen Barclays interne Modelle den fairen Wert zwischen $9,459 und $9,959, was eingebettete Verkaufsprovisionen, Absicherungskosten und Emittentenmarge widerspiegelt. UBS Financial Services fungiert als Platzierungsagent für gebührenbasierte Beratungskonten; es werden keine Verkaufsprovisionen gezahlt.

Risikohinweise dominieren die Offenlegung: Die Notes sind unbesicherte, nicht nachrangige Verbindlichkeiten von Barclays und unterliegen den Bail-in-Maßnahmen des Vereinigten Königreichs, dem Marktrisiko des S&P 500, begrenzter Liquidität (keine Börsennotierung und diskretionäres Sekundärmarkt-Making), steuerlicher Unsicherheit (mögliche Behandlung als vorausbezahlter Terminkontrakt) und Bewertungsrisiko (Sekundärmarktpreise wahrscheinlich unter dem Ausgabepreis).

Beispielszenarien zeigen, dass ein Indexanstieg von 30% die maximale Zahlung von $12,165 ergibt, während ein Rückgang von 60% nur $5,00 einbringt—was das begrenzte Aufwärtspotenzial und den gepufferten, aber erheblichen Abwärtsrisiko verdeutlicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DeSisto Duane M

(Last) (First) (Middle)
C/O MODULAR MEDICAL, INC.
10740 THORNMINT ROAD

(Street)
SAN DIEGO, CA 92127

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 06/30/2025 A 2,500 A (1) 269,890 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.
/s/ James Sullivan, attorney-in-fact for Duane M. DeSisto 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What is the Upside Gearing on Barclays' Capped Buffer GEARS?

The notes offer 2.0× leveraged exposure to any positive S&P 500 return, subject to the Maximum Gain.

How much principal protection do investors have in these securities?

There is a 10% Buffer; full principal is returned only if the index decline does not exceed 10% at maturity.

What is the Maximum Gain investors can earn?

The cap will be set on the Trade Date between 21.65% and 23.65%, corresponding to a maximum payment of $12.165-$12.365 per $10 note.

When do the Barclays Capped Buffer GEARS mature?

The notes are scheduled to mature on July 20, 2027, approximately two years after the July 15, 2025 Trade Date.

Are the securities listed on an exchange?

No. The notes will not be listed; liquidity depends on Barclays Capital Inc. making a secondary market, which it is not obligated to do.

Why is the estimated value lower than the $10 issue price?

The $9.459-$9.959 estimate reflects hedging costs, structuring fees and issuer profit; investors pay a premium over model value at issuance.
Modular Med Inc

NASDAQ:MODD

MODD Rankings

MODD Latest News

MODD Latest SEC Filings

MODD Stock Data

35.21M
51.07M
8.26%
43.67%
0.64%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO